TradingView
GregFolin
Feb 4, 2020 6:15 PM

$PMCB Turns the Corner 

Description

PMCB displays a very clear change in direction of trend following a basing process that includes a type specimen MACD Bullish Divergence.

------------------------------------

Pharmacyte Biotech Inc (OTCMKTS:PMCB)

Pharmacyte trumpets itself as a clinical stage biotechnology company that focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States.

Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes.

The company is developing therapies for pancreatic and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the activation of cancer-killing drugs to the source of the cancer. It is also developing a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes; and therapies for cancer based on the constituents of the cannabis plant.
Comments
wicked007
Hi @TraderSalad do you still hold positions in this company - I just came across it from soon else - just curious to know what you think?
TraderSalad
@wicked007, I do , 5000 shr's and reading promising reports on FDA approval for " Cell in the Box "cancer treatments.
TraderSalad
"Preparations for the IND began quite some time ago and are still on-going. We are going as fast as responsibly possible. Facet Life Sciences, our regulatory affairs consultant, will be submitting the completed IND application to the FDA on PharmaCyte's behalf." Update from the company yesterday.
TraderSalad
Anyone hear any news on PMCB ? Big gap down today for no apparent reason except maybe delay in the IND filing ....
TraderSalad
I am holding a position in this company and continue to accumulate at these price points. The initial data for testing in humans is in and the company is formalizing its filing with the FDA for trials. i normally am not patient with these biotech plays but this one intrigues me as I am a diabetic and see the therapies that they are developing as very useful. My approximate time frame for real movement is in the next 30 -90 days.
More